Grown Rogue International Inc
Grown Rogue International Inc., a craft cannabis company, focuses on premium flower and flower-derived products. It produces a range of cultivars for consumers, which are classified as indicas, sativas, and hybrids. The company sells its products through dispensaries. Grown Rogue International Inc. was incorporated in 1978 and is headquartered in Medford, Oregon.
Grown Rogue International Inc (GRUSF) - Net Assets
Latest net assets as of July 2025: $32.24 Million USD
Based on the latest financial reports, Grown Rogue International Inc (GRUSF) has net assets worth $32.24 Million USD as of July 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($55.90 Million) and total liabilities ($23.66 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $32.24 Million |
| % of Total Assets | 57.67% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | 904.91 |
Grown Rogue International Inc - Net Assets Trend (2008–2024)
This chart illustrates how Grown Rogue International Inc's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Grown Rogue International Inc (2008–2024)
The table below shows the annual net assets of Grown Rogue International Inc from 2008 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-10-31 | $15.91 Million | +26.76% |
| 2023-10-31 | $12.55 Million | +5169.26% |
| 2022-10-31 | $-247.60K | -103.48% |
| 2021-10-31 | $7.12 Million | +853.48% |
| 2020-10-31 | $-945.02K | +33.81% |
| 2019-10-31 | $-1.43 Million | -476.58% |
| 2018-10-31 | $-247.60K | +35.92% |
| 2017-10-31 | $-386.42K | +26.76% |
| 2016-10-31 | $-527.59K | +78.39% |
| 2015-10-31 | $-2.44 Million | +2.37% |
| 2014-10-31 | $-2.50 Million | -1954.84% |
| 2013-10-31 | $134.84K | -95.46% |
| 2012-10-31 | $2.97 Million | -31.08% |
| 2011-10-31 | $4.31 Million | +7.82% |
| 2010-10-31 | $4.00 Million | +1403.15% |
| 2009-10-31 | $265.99K | +403.23% |
| 2008-10-31 | $-87.72K | -- |
Equity Component Analysis
This analysis shows how different components contribute to Grown Rogue International Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 3218870179.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (October 2024)
| Component | Amount | Percentage |
|---|---|---|
| Other Components | $47.40 Million | 325.73% |
| Total Equity | $14.55 Million | 100.00% |
Grown Rogue International Inc Competitors by Market Cap
The table below lists competitors of Grown Rogue International Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
F & M Bank Corp
OTCQX:FMBM
|
$53.77 Million |
|
DIRTT Environmental Solutions Ltd
PINK:DRTTF
|
$53.81 Million |
|
Realia
MC:RLIA
|
$53.81 Million |
|
Realia Business S.A.
LSE:0KBV
|
$53.81 Million |
|
Frontage Holdings Corporation
PINK:FGHQF
|
$53.77 Million |
|
Future Vision II Acquisition Corporation Units
NASDAQ:FVNNU
|
$53.76 Million |
|
Smart Radar System Inc.
KQ:424960
|
$53.76 Million |
|
BTCS INC. DL-001
F:BIC
|
$53.75 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Grown Rogue International Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 11,567,764 to 14,551,768, a change of 2,984,004 (25.8%).
- Net loss of 11,303,642 reduced equity.
- Share repurchases of 126,914 reduced equity.
- Other comprehensive income increased equity by 108,068.
- Other factors increased equity by 14,306,492.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-11.30 Million | -77.68% |
| Share Repurchases | $126.91K | -0.87% |
| Other Comprehensive Income | $108.07K | +0.74% |
| Other Changes | $14.31 Million | +98.31% |
| Total Change | $- | 25.80% |
Book Value vs Market Value Analysis
This analysis compares Grown Rogue International Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 5.35x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2008-10-31 | $-0.15 | $0.35 | x |
| 2009-10-31 | $0.21 | $0.35 | x |
| 2010-10-31 | $2.27 | $0.35 | x |
| 2011-10-31 | $1.89 | $0.35 | x |
| 2012-10-31 | $5.09 | $0.35 | x |
| 2013-10-31 | $0.18 | $0.35 | x |
| 2014-10-31 | $-2.76 | $0.35 | x |
| 2015-10-31 | $-0.91 | $0.35 | x |
| 2016-10-31 | $-0.36 | $0.35 | x |
| 2017-10-31 | $-0.02 | $0.35 | x |
| 2018-10-31 | $-0.01 | $0.35 | x |
| 2019-10-31 | $-0.02 | $0.35 | x |
| 2020-10-31 | $-0.01 | $0.35 | x |
| 2021-10-31 | $0.04 | $0.35 | x |
| 2022-10-31 | $0.00 | $0.35 | x |
| 2023-10-31 | $0.07 | $0.35 | x |
| 2024-10-31 | $0.07 | $0.35 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Grown Rogue International Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -77.68%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -41.84%
- • Asset Turnover: 0.62x
- • Equity Multiplier: 2.98x
- Recent ROE (-77.68%) is above the historical average (-197.43%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2008 | 0.00% | -17299.02% | 0.00x | 0.00x | $-38.78K |
| 2009 | -123.63% | -585.17% | 0.09x | 2.26x | $-355.46K |
| 2010 | -16.24% | -653.59% | 0.02x | 1.44x | $-1.05 Million |
| 2011 | -17.83% | -1048.34% | 0.01x | 2.25x | $-1.20 Million |
| 2012 | -95.22% | -7163.09% | 0.00x | 3.05x | $-3.13 Million |
| 2013 | -3001.23% | -14191.03% | 0.00x | 48.67x | $-4.06 Million |
| 2014 | 0.00% | -9405.27% | 0.01x | 0.00x | $-5.37 Million |
| 2015 | 0.00% | -5079.67% | 0.57x | 0.00x | $-1.79 Million |
| 2016 | 0.00% | 0.00% | 0.00x | 0.00x | $-10.28 Million |
| 2017 | 0.00% | -193.76% | 4.69x | 0.00x | $-263.76K |
| 2018 | 0.00% | -388.69% | 0.36x | 0.00x | $-7.49 Million |
| 2019 | 0.00% | -247.53% | 1.34x | 0.00x | $-9.57 Million |
| 2020 | 0.00% | -74.41% | 1.13x | 0.00x | $-3.06 Million |
| 2021 | -19.95% | -10.82% | 0.66x | 2.79x | $-1.52 Million |
| 2022 | 0.00% | 2.52% | 3.31x | 0.00x | $472.22K |
| 2023 | -4.48% | -2.28% | 0.75x | 2.61x | $-1.67 Million |
| 2024 | -77.68% | -41.84% | 0.62x | 2.98x | $-12.76 Million |
Industry Comparison
This section compares Grown Rogue International Inc's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.
Industry Context
- Industry: Drug Manufacturers - Specialty & Generic
- Average net assets among peers: $439,452,927
- Average return on equity (ROE) among peers: -31.68%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Grown Rogue International Inc (GRUSF) | $32.24 Million | 0.00% | 0.73x | $53.77 Million |
| Ascend Wellness Holdings Inc (AAWH) | $71.80 Million | -118.37% | 11.54x | $48.90 Million |
| AB Science S.A (ABSCF) | $-21.01 Million | 0.00% | 0.00x | $39.89 Million |
| Alterola Biotech Inc (ABTI) | $-294.68K | 0.00% | 0.00x | $603.58K |
| Aurora Cannabis Inc (ACB) | $521.74 Million | -156.52% | 0.78x | $195.20 Million |
| Acreage Holdings Inc (ACRDF) | $494.79 Million | -30.37% | 0.40x | $13.48K |
| Acura Pharmaceuticals Inc (ACUR) | $29.91 Million | 0.00% | 0.07x | $13.20K |
| Agra Ventures Ltd. (AGFAF) | $1.72 Million | -18.78% | 0.11x | $298.23K |
| Allergy Therapeutics plc (AGYTF) | $20.08 Million | -10.91% | 0.33x | $25.30 Million |
| Aida Pharmaceuticals Inc (AIDA) | $21.19 Million | 12.93% | 1.96x | $1.85 |
| Adcock Ingram Holdings Limited (AIHLF) | $3.25 Billion | 5.19% | 0.72x | $85.61 Million |